A study by Mann et al. found that increased levels of α2-Na/K adenosine triphosphatase (α2-NKA) in astrocytes were present in AD and that reducing α2-NKA prevented the buildup of tau [141] (Fig. 2). This evidence concerns the gene MAPT and Alzheimer disease.